ECS Botanics Holdings (ASX:ECS) Accumulated Depreciation: A$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ECS Botanics Holdings Accumulated Depreciation?

ECS Botanics Holdings ASX:ECS Accumulated Depreciation is A$0.00 Mil as of Dec. 2025. The stock has 9 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

ECS Botanics Holdings's quarterly accumulated depreciation increased from Dec. 2024 (A$0.00 Mil) to Jun. 2025 (A$-3.42 Mil) but then stayed the same from Jun. 2025 (A$-3.42 Mil) to Dec. 2025 (A$0.00 Mil).

ECS Botanics Holdings's annual accumulated depreciation increased from Jun. 2023 (A$-1.29 Mil) to Jun. 2024 (A$-2.31 Mil) and increased from Jun. 2024 (A$-2.31 Mil) to Jun. 2025 (A$-3.42 Mil).

ECS Botanics Holdings Accumulated Depreciation Related Terms

ECS Botanics Holdings Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for ECS Botanics Holdings's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ECS Botanics Holdings Accumulated Depreciation Chart

ECS Botanics Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.24 -0.70 -1.29 -2.31 -3.42

ECS Botanics Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -2.31 0.00 -3.42 0.00

ECS Botanics Holdings Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of A$0.00 Mil mean?
ECS Botanics Holdings (ASX:ECS) has a Accumulated Depreciation of A$0.00 Mil as of Dec. 2025. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on ECS Botanics Holdings and its competitors.
Is ECS Botanics Holdings' Accumulated Depreciation too high?
ECS Botanics Holdings' current Accumulated Depreciation is A$0.00 Mil.
How does ECS Botanics Holdings' Accumulated Depreciation compare to ZTS?
ECS Botanics Holdings' Accumulated Depreciation of A$0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on ECS Botanics Holdings and its competitors. ECS Botanics Holdings's current Accumulated Depreciation is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ECS Botanics Holdings stock overvalued right now?
Based on GuruFocus' analysis, ECS Botanics Holdings (ASX:ECS) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.01 — trading 70% below its estimated fair value. The current Accumulated Depreciation is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For ECS Botanics Holdings (ASX:ECS), the current Accumulated Depreciation is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ECS Botanics Holdings Business Description

Address 899 River Road, Murrabit West, Murrabit, VIC, AUS, 3579
ECS Botanics Holdings Ltd is an Australian medicinal cannabis cultivator and manufacturer located in Northwest Victoria. The company utilizes progressive cultivation methodologies to produce quality medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. Licensed by the Therapeutic Drug Administration to manufacture PIC/S GMP certified products, the company provides quality, affordable medicinal cannabis, supplying both local and overseas markets.